Suvadronabinol

N/A

Report date: 2025/05/20 15:34:37

Base Information

Drug NameSuvadronabinol
Drug Alias NameProprietary prodrug of tetrahydrocannabinol (Skye Bioscience)SBI-100 Ophthalmic Emulsion (Skye Bioscience)SBI-100 ophthalmic nanoemulsion (Skye Bioscience)Tetrahydrocannabinol valine hemisuccinateSBI-100 +[13] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCannabinoid CB1 receptor agonists
TargetsCannabinoid CB1 receptor
Therapy Area/IndicationsGlaucoma, Open-AngleGlaucomaOcular Hypertension
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesAustralia
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Mississippi
China Registration ClassN/A

Develop Information

Active CompaniesNextpharma Technologies IncTautomer Bioscience (Pty) LtdSkye Bioscience Inc +[4] 
Inactive CompaniesN/A
Active IndicationsGlaucoma, Open-AngleGlaucomaOcular Hypertension
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksWikipedia